Get started
Nykode Therapeutics ASANykode Therapeutics ASANykode Therapeutics ASA

Nykode Therapeutics ASA

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityForecastsSeasonals
Full chart
Full chart

Key stats


Market capitalization
‪1.04 B‬ NOK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.455 NOK
Net income (FY)
‪−127.10 M‬ NOK
Revenue (FY)
0.00 NOK
Shares float
‪170.88 M‬
Beta (1Y)
0.39

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
59
Change (1Y)
−80−57.55%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

Details


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Michael Thyrring Engsig
Website
nykode.com
Headquarters
Oslo
Founded
2006
IPO date
Jan 27, 2020
ISIN
NO0010714785
FIGI
BBG01GNB59F2
Identifiers
ISIN NO0010714785
CFI code
ESVUFR
Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. It focuses on developing field of individualized cancer neoantigen vaccines by using the Vaccibody technology to generate therapeutics to treat cancer. The company was founded by Inger Sandlie and Agnete Brunsvik Fredriksen on November 22, 2006 and is headquartered in Oslo, Norway.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


Depending on the exchange, the stock ticker may vary. For instance, on AQUISEU exchange Nykode Therapeutics ASA stocks are traded under the ticker NYKDO.
We've gathered analysts' opinions on Nykode Therapeutics ASA future price: according to them, NYKDO price has a max estimate of 5.51 NOK and a min estimate of 4.51 NOK. Watch NYKDO chart and read a more detailed Nykode Therapeutics ASA stock forecast: see what analysts think of Nykode Therapeutics ASA and suggest that you do with its stocks.
NYKDO reached its all-time high on Jun 16, 2023 with the price of 30.840 NOK, and its all-time low was 1.450 NOK and was reached on Sep 10, 2025. View more price dynamics on NYKDO chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Nykode Therapeutics ASA financials in yearly and quarterly reports right on TradingView.
Nykode Therapeutics ASA is going to release the next earnings report on Aug 26, 2026. Keep track of upcoming events with our Earnings Calendar.
NYKDO net income for the last quarter is ‪−40.01 M‬ NOK, while the quarter before that showed ‪−80.71 M‬ NOK of net income which accounts for 0.00% change. Track more Nykode Therapeutics ASA financial stats to get the full picture.
Yes, NYKDO dividends are paid annually. The last dividend per share was 1.00 NOK. As of today, Dividend Yield (TTM)% is 31.40%. Tracking Nykode Therapeutics ASA dividends might help you take more informed decisions.
As of Jul 31, 2026, the company has 59 employees. See our rating of the largest employees — is Nykode Therapeutics ASA on this list?
Like other stocks, NYKDO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nykode Therapeutics ASA stock right from TradingView charts — choose your broker and connect to your account.